101 



23. Henningfield et al . Drug and alcohol dependence. 1993:23-29 

 citing Benowitz N. National Institute of Drug Abuse Research 

 Monograph pp. 12-29. 



24. Gardner, Eliot L. Brain Reward Mechanisms. Substance Abuse: A 

 Comprehensive Textbook. Second Edition. William and Wilkens. 

 1992. 



25. Yokel, Ra . Intravenous self -administration : Response rates, 

 the effects of pharmacological challenges, and drug 

 preference: Methods of Assessing the Reinforcing Properties of 

 Abused Drugs. Spring-Verlag. 1987. 



26. DiChiara, G. and Imperato, A. Drugs abused by humans 

 preferentially increase synaptic dopamine concentrations in 

 the mesolimbic system of freely moving rats. Proceedings of 

 the National Academy of Sciences. Vol. 85: July 1988:5274-78. 



27. Department of Health and Human Services, Public Health 

 Service. The Health Consequences of Smoking: Nicotine 

 Addiction. A report of the Surgeon General. DHHS (CDC) 1988. 

 Publication no: 88-8406. 



28. Imperato, A., Mulas A., and DiChiara, G. Nicotine 

 preferentially stimulates dopamine release in the limbic 

 system of freely moving rats. European Journal of 

 Pharmacology. 1986;132:337-338. 



29. Corrigall, WA. , Franklin, KBJ., Coen, KM. and PBS Clarke. The 

 mesolimbic dopaminergic system is implicated in the 

 reinforcing effects of nicotine. Psychopharmacology . 

 1992;107:285-289. 



30. Corrigall, WA. and Coen, KM. Selective dopamine antagonists 

 reduce nicotine self -administration. Psychopharmacology. 

 1991;104 ;171-176. 



31. Robinson JH. and Pritchard, WS . The role of nicotine in 

 tobacco use. Psychopharmacology. 1992;108:397-407. 



Rosenblatt, R. How do they live with themselves? New York 

 Times Magazine. March 20, 1994. 



32. Henningfield Ph.D., J.E., Schiffman Ph.D., S. Informal 

 communications . 



33. U.S. patent no. 4,595,024 Cl:33-36. 



34. U.S. patent no. 4,676,259 Cl:21-24. 



35. U.S. patent no. 3,280,823 Cl:43-48. 



31 



